MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: MYCOPHENOLATE MOFETIL; Generic name: MYCOPHENOLATE MOFETIL; Manufacturer: NorthStar Rx LLC.
| Brand name | MYCOPHENOLATE MOFETIL |
|---|---|
| Generic name | MYCOPHENOLATE MOFETIL |
| Manufacturer | NorthStar Rx LLC |
| Used for | 1 INDICATIONS AND USAGE Mycophenolate mofetil for oral suspension (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION ADULTS DOSAGE Kidney Transplant 1 g twice daily, orally ( 2.2 ) Heart Transplant 1.5 g twice daily orally ( 2.3 ) Liver Transplant 1.5 g twice daily orally ( 2.4 ) PEDIATRICS Kidney Transplant 600 mg/m 2 orally twice daily, up to maximum of 2 g daily ( 2.2 ) Heart Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g or 15 mL of oral suspension) ( 2.3 ) Liver Transplant 600 mg/m 2 orally twice daily (starting dose) up |
| Warnings | WARNING: EMBRYOFETAL TOXICITY, MALIGNANCIES and SERIOUS INFECTIONS Use during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1) , Use in Special Populations ( 8.1 , 8.3 )] . Increased risk of development of lymphoma and other malignancies, particularly of the s |
| Active ingredient(s) | MYCOPHENOLATE MOFETIL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=127eabe2-8386-452a-ad6b-d879e1f2c099 |